All respiratory syncytial virus articles
-
NewsScientists pinpoint new drug target for RSV
Scientists have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so, they have pinpointed an exciting new target for drug developers.
-
NewsStudy backs RSV vaccine safety during pregnancy
Vaccinating mothers against respiratory syncytial virus (RSV) during late pregnancy to protect their newborns is not associated with an increased risk of preterm birth or other poor outcomes, according to a new study.
-
NewsBiotech companies leverage novel tools to develop drugs for RSV
Reporter structures that can be introduced into cells for use in drug screening assays emit fluorescent or bioluminescent light at different intensities when RSV genes are inhibited by the potential antiviral agents being tested.
-
NewsNew tool may help prioritize high-risk infants for RSV immunization
On the heels of a shortage of nirsevimab for infant respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) prevention, a new tool may help identify newborns at highest risk for developing serious infections.
-
NewsSevere lung damage caused when flu is followed by infection with measles-like virus
Infection with a measles-like virus causes catastrophic lung failure in ferrets previously infected with influenza virus or respiratory syncytial virus, according to a new study.
-
NewsGut microbiota influence severity of respiratory viral infection
The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, a new study reveals.
-
News Real life data reveals success in controlling respiratory syncytial virus
Early data after passive immunisation with a monoclonal antibody against severe respiratory syncytial virus in 2023 show a decline in hospitalisations and length of stay especially in the most vulnerable group of infants under the age of six months.
-
NewsRSV shown to infect nerve cells, causing inflammation and damage
Long thought to only infect the respiratory tract, RSV has been found to infect nerve cells, cause nerve damage and enter the spinal cord, potentially granting access to the central nervous system.
-
NewsFirst results in using new tools to tackle respiratory syncytial virus
Vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent respiratory syncytial virus (RSV) among young children. Are those tools working?
-
NewsWHO makes request to China for information on pneumonia cluster reports in children
WHO has made an official request to China for detailed information on an increase in respiratory illnesses and reported clusters of pneumonia in children.
-
NewsThousands of children’s operations ’will have to be cancelled’ this winter as UK government delays RSV vaccine
Babies could be needlessly hospitalised this winter because the government has delayed a vaccine that protects them from a life-threatening virus, the UK’s top children’s doctor has warned.
-
NewsBreath test rapidly detects COVID-19 virus
Scientists have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a minute.
-
NewsAntibiotics do not reduce risk of dying in adults hospitalised with common respiratory infections, suggests study
Most patients admitted to hospital with acute viral respiratory infections are given antibiotics. Now new research to be presented at this year’s ECCMID in Copenhagen suggests that prescribing antibiotic therapy to adults hospitalised with common viral respiratory infections such as influenza is unlikely to save lives.
